These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 20598761

  • 1. Effects of clinical and laboratory variables and of pretreatment with cardiovascular drugs in acute ischaemic stroke: a retrospective chart review from the GIFA study.
    Tuttolomondo A, Di Sciacca R, Di Raimondo D, Pedone C, La Placa S, Pinto A, Licata G.
    Int J Cardiol; 2011 Sep 15; 151(3):318-22. PubMed ID: 20598761
    [Abstract] [Full Text] [Related]

  • 2. Effects of clinical and laboratory variables at admission and of in-hospital treatment with cardiovascular drugs on short term prognosis of ischemic stroke. The GIFA study.
    Tuttolomondo A, Di Raimondo D, Di Sciacca R, Pedone C, La Placa S, Arnao V, Pinto A, Licata G.
    Nutr Metab Cardiovasc Dis; 2013 Jul 15; 23(7):642-9. PubMed ID: 22502765
    [Abstract] [Full Text] [Related]

  • 3. Predictors of outcome in acute ischemic cerebrovascular syndromes: The GIFA study.
    Tuttolomondo A, Pedone C, Pinto A, Di Raimondo D, Fernandez P, Di Sciacca R, Licata G, Gruppo Italiano di Farmacoepidemiologia dell'Anziano (GIFA) researchers.
    Int J Cardiol; 2008 Apr 25; 125(3):391-6. PubMed ID: 17490764
    [Abstract] [Full Text] [Related]

  • 4. Impact of the additive effect of angiotensin-converting enzyme inhibitors and /or statins with antiplatelet medication on mortality after acute ischaemic stroke.
    Hassan Y, Al-Jabi SW, Aziz NA, Looi I, Zyoud SH.
    Basic Clin Pharmacol Toxicol; 2012 Apr 25; 110(4):370-7. PubMed ID: 22023326
    [Abstract] [Full Text] [Related]

  • 5. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
    Miedema I, Uyttenboogaart M, Koopman K, De Keyser J, Luijckx GJ.
    Cerebrovasc Dis; 2010 Feb 25; 29(3):263-7. PubMed ID: 20090317
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T, Linjer E, Hedner T, Lanke J, De Faire U, Wester PO, Dahlöf B, Scherstén B.
    Blood Press; 2004 Feb 25; 13(3):137-41. PubMed ID: 15223721
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin 2 type 2 receptor activity and ischemic stroke severity.
    Ovbiagele B, Kidwell CS, Starkman S, Selco SL, Rajajee V, Razinia T, Saver JL.
    Neurology; 2005 Sep 27; 65(6):851-4. PubMed ID: 16186522
    [Abstract] [Full Text] [Related]

  • 8. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
    Lee JH, Yang DH, Park HS, Cho Y, Jeong MH, Kim YJ, Kim KS, Hur SH, Seong IW, Hong TJ, Cho MC, Kim CJ, Jun JE, Park WH, Chae SC, Korea Acute Myocardial Infarction Registry Investigators.
    Am Heart J; 2010 Jun 27; 159(6):1012-9. PubMed ID: 20569714
    [Abstract] [Full Text] [Related]

  • 9. Treatment of acute ischaemic stroke with the low-affinity, use-dependent NMDA antagonist AR-R15896AR. A safety and tolerability study.
    Diener HC, AlKhedr A, Busse O, Hacke W, Zingmark PH, Jonsson N, Basun H, Study group.
    J Neurol; 2002 May 27; 249(5):561-8. PubMed ID: 12021946
    [Abstract] [Full Text] [Related]

  • 10. Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk.
    Kumar S, Savitz S, Schlaug G, Caplan L, Selim M.
    Neurology; 2006 Apr 25; 66(8):1153-8; discussion 1135. PubMed ID: 16636230
    [Abstract] [Full Text] [Related]

  • 11. Risk factors and in-hospital outcomes in stroke and myocardial infarction patients.
    Ivanusa M, Ivanusa Z.
    BMC Public Health; 2004 Jul 05; 4():26. PubMed ID: 15236659
    [Abstract] [Full Text] [Related]

  • 12. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ, Schenk B, Tietz V, Schenkel J, Heuschmann PU.
    Cerebrovasc Dis; 2008 Jul 05; 26(2):171-7. PubMed ID: 18628615
    [Abstract] [Full Text] [Related]

  • 13. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
    Torgano G, Zecca B, Monzani V, Maestroni A, Rossi P, Cazzaniga M, Manganaro D, Boiti C, Zilioli E, Borutti G, Falaschi F, Mandelli C.
    Cerebrovasc Dis; 2010 Feb 05; 29(3):275-81. PubMed ID: 20090319
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
    Shiotsuki H, Ogushi Y, Fushimi K, Kobayashi S, Japanese Standard Stroke Registry Study (JSSRS) Group.
    Tokai J Exp Clin Med; 2005 Apr 05; 30(1):49-62. PubMed ID: 15952299
    [Abstract] [Full Text] [Related]

  • 15. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.
    Hypertens Res; 2007 Apr 05; 30(4):301-6. PubMed ID: 17541208
    [Abstract] [Full Text] [Related]

  • 16. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre.
    Haddad H, Searles G, Gillis A.
    Can J Cardiol; 2001 Feb 05; 17(2):179-83. PubMed ID: 11223488
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcome as function of blood pressure in acute ischemic stroke and effects of thrombolysis.
    Yong M, Diener HC, Kaste M, Mau J.
    Cerebrovasc Dis; 2007 Feb 05; 24(4):349-54. PubMed ID: 17690547
    [Abstract] [Full Text] [Related]

  • 18. Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke.
    Qureshi AI, Kirmani JF, Sayed MA, Safdar A, Ahmed S, Ferguson R, Hershey LA, Qazi KJ, Buffalo Metropolitan Area and Erie County Stroke Study Group.
    Neurology; 2005 Jun 28; 64(12):2115-20. PubMed ID: 15985583
    [Abstract] [Full Text] [Related]

  • 19. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
    Masrur S, Abdullah AR, Smith EE, Hidalgo R, El-Ghandour A, Rordorf G, Schwamm LH.
    J Stroke Cerebrovasc Dis; 2011 Jun 28; 20(2):124-30. PubMed ID: 20598579
    [Abstract] [Full Text] [Related]

  • 20. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality.
    Elkind MS, Flint AC, Sciacca RR, Sacco RL.
    Neurology; 2005 Jul 26; 65(2):253-8. PubMed ID: 16043795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.